Cryoport and the Cell and Gene Therapy Catapult have entered into a new strategic partnership to support the advancement of cell and gene therapies. As part of the deal, Cryoport will establish a Good Manufacturing Practice (GMP)-compliant global supply chain logistics centre in the UK at… Read More
This is the latest episode of the free DDW narrated podcast, “A business case for drug discovery”, which covers three articles written for Volume 23, Issue 3 – Summer 2022 of DDW. They are called “A deal in the making”, “Why project management… Read More
Seven pharmaceutical companies have announced a joint initiative to reduce near-term emissions and help develop net zero health systems. CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi announced commitments to tackle climate change through the Sustainable Markets Initiative (SMI) Health… Read More
Listen to this article on the DDW Podcast: David Lewandowski, Business Director of Cell & Gene Therapy at Azenta Life Sciences, explains how efficient sample management can help to work efficiently and bring therapies to market faster. The global cell and gene therapy (CGT) market reached a value of… Read More
The LSX World Congress returned for an in-person event in May, bringing together executives from the biotech, medtech and healthtech sectors, across two days to examine the latest trends across life sciences. DDW’s Reece Armstrong attended the event – here are the key takeaways from the show. Read More
Cytiva offer solutions to support work from biological research to clinical therapy, including tools for research, drug discovery, diagnostics and bioprocessing. Ryan Walker, the Sustainability Program Leader at Cytiva, discussed with DDW’s Megan Thomas the steps Cytiva is making to make their vision of a more sustainable… Read More
Eugene Polini, Technical Key Account Manager at Datwyler examines the challenges drug developers are facing to speed up production lifecycles and what solutions are available to them. While people around the world hope to never see another global pandemic in their lifetimes, it is the responsibility of pharmaceutical manufacturers to… Read More
Immunotherapy company Ilya Pharma has acquired Nordic Bioanalysis in a move to strengthen its supply chain and help develop its pipeline of skin and mucosal immunotherapy drug candidates. Nordic Bioanalysis was founded in 2019 and serves as an international expert in bioanalytical development and validation for pharmaceuticals,… Read More
